Pharma

Latest posts

We need the people's prescription to fix pharma


19 October 2018

Our new report ‘The people’s prescription: Re-imagining health innovation to deliver public value’ reveals how pharmaceutical companies not only charge unaffordable prices for medicines, they are also not delivering the drugs we need. It’s a scandal of our time but there are alternatives to a system that puts profits above public need. 

Challenging the corporate control of medicines: 10 highlights


08 October 2018

Amazingly it’s one year on from the launch of our pharmaceuticals campaign. Time has flown, but together, we’ve achieved a lot. A huge thank you to all our supporters, members and local groups for challenging the corporate control of medicines.

Our NHS at 70 is still amazing. Why isn't there an NHS for the world?


05 July 2018

The National Health Service turns 70 today. Despite too many years of austerity cuts, contracting out and PFIs, most of us still feel the NHS is one of the defining achievements of our society.

Latest news

NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

Global protests ahead of Novartis AGM in Switzerland tomorrow. Call for new CEO to clean up company following scandals in Colombia and Greece.

Campaign groups Global Justice Now and STOPAIDS have welcomed a statement by NHS England to the BBC’s 5 Live Investigates this morning that “further regulatory action may be needed” on drug pricing at a time when NHS funding is under severe pressure.

Resources

Resource thumbail

The people’s prescription: Re-imagining health innovation to deliver public value

October 2018

Driven by profit rather than public health, the pharmaceutical sector is incentivised to set high prices and deliver short-term returns to shareholders, rather than focus on riskier, longer-term research which leads to critically needed therapeutic advances. The high prices of medicines are causing severe patient access problems worldwide, with damaging consequences for human health and wellbeing. These are symptoms of an innovation model that is broken. This report maps the fault lines of this system and sets out principles for a new one.

Pharma - NHS birthday A5 leaflet

May 2018

As the NHS turns 70, it is locked in a crisis of underfunding. The reasons are many, from government funding cuts to the massive debts racked up as a result of Private Finance Initiatives. But one factor that gets less notice is the rip-off prices the pharmaceutical industry charges for a huge range of drugs.

Resource thumbail

Pharmaceutical campaign: activist lobby guide

March 2018

This briefing provides the key talking points that you can use in a meeting with your MP about our campaign for affordable medicines. The briefing is intended to help you lobby:

- An MP who has not taken action on this campaign

- An MP who has taken action on this campaign or

-An MP that is a member of the business, health or public accounts committees

Please use the lobbying advice that is most relevant to your MP.